Literature DB >> 22795547

Ischemia changes and tolerance ratio of evoked potential monitoring in intracranial aneurysm surgery.

Dezhi Kang1, Peisen Yao, Zanyi Wu, Lianghong Yu.   

Abstract

OBJECTIVE: We assessed the relationship between cerebral ischemia-induced changes in evoked potentials and the degree of ischemia tolerance.
METHODS: 47 patients underwent somatosensory evoked potential (SEP) and motor evoked potential (MEP) monitoring in intracranial aneurysm surgery. Three duration parameters (time) were recorded: Time 1, from the starting of temporary occlusion unavoidable in aneurysm surgery to the time the evoked potentials decrease from basal level to reaching the warning criterion; Time 2, from evoked potentials reaching the warning criterion to the time the blood flow was resumed; Time 3, after resuming the blood flow, the time it took the evoked potentials to recover to baseline. All three times can be reliably calculated in the SEP recording, but not in the MEP recording which consisted of either unchanged amplitudes or abruptly changing amplitudes, making it impossible to obtain Time 1. The ischemic tolerance ratio (ITR) was calculated as ITR=time 2/time 1×100%. New decreasing myodynamia and fresh infarction after the surgery were employed for evaluating neurological deficits postoperatively, and their correlations with the ischemia-induced changes of evoked potentials recorded during the surgery were analyzed.
RESULTS: We found a change in SEPs in 12 patients whose cerebral ischemia was induced by temporary occlusion of the aneurysm's parent artery. We also found the development of postoperative neurological deficits in 4 patients whose ischemic tolerance ratio (ITR) reached over 80%, while no deficits were found in the other 8 patients whose ITR was less than 50%. MEP changes were seen in 4 patients whose cerebral ischemia was caused by accidentally clamping the perforating branches, causing the development of postoperative neurological deficits but not necessarily leading to significant SEP changes.
CONCLUSION: The Ischemia tolerance ratio (ITR) in SEP recordings is valuable to predicting postoperative neurological deficits caused by temporary occlusion of aneurysm's parent artery. Maintaining the ITR under 50% during operation can effectively avoid postoperative neurological deficits, while an ITR above 80% reliably forecasts postoperative neurological deficits. Complementary to SEPs, MEP recordings are particularly valuable in monitoring ischemic effects caused by accidentally clamping perforating branches. Taken together, this system of monitoring makes it possible to promptly adjust surgery procedures and minimize postoperative neurological deficits.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22795547     DOI: 10.1016/j.clineuro.2012.06.029

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  4 in total

1.  Intraoperative monitoring of motor-evoked potentials for supratentorial tumor surgery.

Authors:  Jung Jae Lee; Young Il Kim; Jae Taek Hong; Jae Hoon Sung; Sang Won Lee; Seung Ho Yang
Journal:  J Korean Neurosurg Soc       Date:  2014-08-31

2.  Risk factors of acute coagulation dysfunction after aneurysmal subarachnoid hemorrhage.

Authors:  Guo-Rong Chen; Pei-Sen Yao; Chu-Bin Liu; Huang-Cheng Shang-Guan; Shu-Fa Zheng; Liang-Hong Yu; Yuan-Xiang Lin; Zhang-Ya Lin; De-Zhi Kang
Journal:  Chin Neurosurg J       Date:  2018-10-08

3.  A new measure for monitoring intraoperative somatosensory evoked potentials.

Authors:  Seung-Hyun Jin; Chun Kee Chung; Jeong Eun Kim; Young Doo Choi
Journal:  J Korean Neurosurg Soc       Date:  2014-12-31

4.  Usefulness of Intraoperative Neurophysiological Monitoring During the Clipping of Unruptured Intracranial Aneurysm: Diagnostic Efficacy and Detailed Protocol.

Authors:  Dougho Park; Byung Hee Kim; Sang-Eok Lee; Eunhwan Jeong; Kwansang Cho; Ji Kang Park; Yeon-Ju Choi; Suntak Jin; Daeyoung Hong; Mun-Chul Kim
Journal:  Front Surg       Date:  2021-02-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.